Benelux
Gimv divests L&C to Nasdaq-listed Nuance
Gimv has sold its stake in technology business Language & Computing (L&C) to Nasdaq-listed Nuance Communications, a provider of speech and imaging solutions for businesses and consumers around the world.
Candover's shares rise as firm hints at new beginnings
Troubled private equity firm Candover's shares went up 8% in early morning today after it reportedly hinted at future plans to raise new funds.
LPs throw out the old for the new
It is now common knowledge that fundraising for private equity funds this year will be tough to say the least. Many, however, do not realise just how tough. News reports this week suggest that LPs are now considering severing ties with some GPs altogether...
Carlyle-backed Bigmouthmedia to merge with LBi
Carlyle-owned marketing specialist Bigmouthmedia is set to merge with Stockholm-listed digital marketing and technology agency, LBi International.
KKR nears NYSE listing; releases fourth quarter results
Private equity behemoth KKR is moving closer to listing on the New York Stock Exchange, as the firm has confirmed the move yet again in its financial results report for the fourth quarter, released yesterday.
Rabo Capital sells stake in Itho Group BV
Rabo Capital, part of Rabo Private Equity (the captive private equity division of Rabobank Group), has sold its majority stake in Itho Group BV to Bencis Capital Partners.
Q&A: Fundraising in 2010 and beyond
Charlie Jolly principal at Matrix talks to Francinia Protti-Alvarez about recent fundraising trends and implications for the future.
IPOs: will they float or flounder?
The recent IPO frenzy will prove a blip, according to a recent unquote” poll. By Rikke Eckhoff
Green spark: Renewables still generating returns
Despite the difficult economic backdrop, environmental infrastructure continues to prove attractive to investors. By Francinia Protti-Alvarez
To SBO or IPO, that is the question
Recent evidence has shown that for good companies the barren exit market of last year has been replaced by a tug-of-war between viable divestment routes, writes Emanuel Eftimiu
Q&A: Early-stage evolution
Bart Diels, partner at Belgian investor Gimv, speaks to Francinia Protti-Alvarez about how the venture market in the Benelux region has adapted to the changing economic climate.
Salans opens office in Brussels
International law firm Salans has opened an office in Brussels which will commence operating as of 1 March.
KBC and ARKimedes invest in Concrete Systems
KBC Private Equity and ARKimedes through their joint subsidiary KBC Arkiv, have invested an undisclosed sum in shuttering solutions manufacturer Concrete System.
Trimming down: Northzone reflects new reality for venture funds
While the newly-launched Northzone fund is in many ways a rare success for European venture fundraising in the current market, its modest target reflects the continuing difficulties in securing commitments. By Rikke Eckhoff.
PTV and Sunstone invest €2.5m in Layar
Prime Technology Ventures (PTV) has together with Sunstone Capital, led a €2.5m series A round for Dutch augmented reality (AR) platform provider Layar.
The only way is up: new poll reveals strong optimism for 2010
Most readers are optimistic for the year ahead - but cynics have good cause for concern. By Kimberly Romaine.
KBC to sell private equity wing
As previously reported in unquote, KBC Groupe NV, a Belgian bank, is set to sell its private equity arm by the end of 2010 having received a number of offers for the division.
Bencis acquires Saval and Knowsley from Imtech
Bencis Capital Partners has acquired extinguishing systems specialists Saval and Knowsley from parent company Imtech.
Bencis-backed Quaron to be acquired by Univar
Bencis Capital has agreed to sell its chemical manufacturer Quaron Group to trade player Univar.
Q&A: Intermediate on high ground
Deborah Sterescu speaks to Christophe Evain, managing director of ICG, on expectations for recovery and why high-yield is not a long-term threat for mezzanine.
Aescap-backed Biocartis acquires Philips Technology Platform
Aescap-backed molecular diagnostics company Biocartis has acquired Philips’ technology platform for rapid fully-automated DNA/RNA molecular diagnostic testing.